Compile Data Set for Download or QSAR
Found 63 Enz. Inhib. hit(s) with all data for entry = 8147
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234579(US9353093, 1)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234580(US9353093, 2)copy SMILEScopy InChI
Affinity DataIC50: 5nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234581(US9353093, 3)copy SMILEScopy InChI
Affinity DataIC50: 6nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234582(US9353093, 4)copy SMILEScopy InChI
Affinity DataIC50: 6nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234583(US9353093, 5)copy SMILEScopy InChI
Affinity DataIC50: 8nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234584(US9353093, 6)copy SMILEScopy InChI
Affinity DataIC50: 9nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234585(US9353093, 7)copy SMILEScopy InChI
Affinity DataIC50: 9nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234579(US9353093, 1)copy SMILEScopy InChI
Affinity DataIC50: 10nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234580(US9353093, 2)copy SMILEScopy InChI
Affinity DataIC50: 10nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234586(US9353093, 8)copy SMILEScopy InChI
Affinity DataIC50: 11nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234587(US9353093, 9)copy SMILEScopy InChI
Affinity DataIC50: 11nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234580(US9353093, 2)copy SMILEScopy InChI
Affinity DataIC50: 11nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234589(US9353093, 11)copy SMILEScopy InChI
Affinity DataIC50: 11nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234586(US9353093, 8)copy SMILEScopy InChI
Affinity DataIC50: 12nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234579(US9353093, 1)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234581(US9353093, 3)copy SMILEScopy InChI
Affinity DataIC50: 14nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234582(US9353093, 4)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234582(US9353093, 4)copy SMILEScopy InChI
Affinity DataIC50: 16nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234581(US9353093, 3)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234583(US9353093, 5)copy SMILEScopy InChI
Affinity DataIC50: 19nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234585(US9353093, 7)copy SMILEScopy InChI
Affinity DataIC50: 20nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234588(US9353093, 10)copy SMILEScopy InChI
Affinity DataIC50: 22nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234588(US9353093, 10)copy SMILEScopy InChI
Affinity DataIC50: 23nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234589(US9353093, 11)copy SMILEScopy InChI
Affinity DataIC50: 23nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234584(US9353093, 6)copy SMILEScopy InChI
Affinity DataIC50: 28nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234585(US9353093, 7)copy SMILEScopy InChI
Affinity DataIC50: 41nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234586(US9353093, 8)copy SMILEScopy InChI
Affinity DataIC50: 45nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234587(US9353093, 9)copy SMILEScopy InChI
Affinity DataIC50: 55nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234584(US9353093, 6)copy SMILEScopy InChI
Affinity DataIC50: 58nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234599(US9353093, 28)copy SMILEScopy InChI
Affinity DataIC50: 60nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234597(US9353093, 26)copy SMILEScopy InChI
Affinity DataIC50: 67nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234601(US9353093, 30)copy SMILEScopy InChI
Affinity DataIC50: 83nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234598(US9353093, 27)copy SMILEScopy InChI
Affinity DataIC50: 93nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234600(US9353093, 29)copy SMILEScopy InChI
Affinity DataIC50: 94nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234583(US9353093, 5)copy SMILEScopy InChI
Affinity DataIC50: 97nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234590(US9353093, 12)copy SMILEScopy InChI
Affinity DataIC50: 118nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234602(US9353093, 31)copy SMILEScopy InChI
Affinity DataIC50: 131nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234587(US9353093, 9)copy SMILEScopy InChI
Affinity DataIC50: 139nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234588(US9353093, 10)copy SMILEScopy InChI
Affinity DataIC50: 150nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234602(US9353093, 31)copy SMILEScopy InChI
Affinity DataIC50: 151nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234598(US9353093, 27)copy SMILEScopy InChI
Affinity DataIC50: 152nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234590(US9353093, 12)copy SMILEScopy InChI
Affinity DataIC50: 174nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234592(US9353093, 20)copy SMILEScopy InChI
Affinity DataIC50: 240nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234594(US9353093, 22)copy SMILEScopy InChI
Affinity DataIC50: 249nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234593(US9353093, 21)copy SMILEScopy InChI
Affinity DataIC50: 254nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234599(US9353093, 28)copy SMILEScopy InChI
Affinity DataIC50: 264nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234591(US9353093, 19)copy SMILEScopy InChI
Affinity DataIC50: 276nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234595(US9353093, 23)copy SMILEScopy InChI
Affinity DataIC50: 334nMpH: 7.4Assay Description:Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg/well of poly-Glu-Tyr (4:1) in 10...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234597(US9353093, 26)copy SMILEScopy InChI
Affinity DataIC50: 508nMAssay Description:Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of VEGF induced increases in intracellular calcium l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
TargetPlatelet-derived growth factor subunit B(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM234597(US9353093, 26)copy SMILEScopy InChI
Affinity DataIC50: 1.14E+3nMpH: 7.4Assay Description:Biochemical PDGFRβ kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 μg of poly-Glu-Tyr (4:1) in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ64ZVUS Patent
Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: